Compare CC & LFST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CC | LFST |
|---|---|---|
| Founded | 2014 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Chemicals | Medical/Nursing Services |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.9B | 2.9B |
| IPO Year | 2014 | 2021 |
| Metric | CC | LFST |
|---|---|---|
| Price | $16.93 | $10.89 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 9 | 6 |
| Target Price | ★ $20.11 | $9.83 |
| AVG Volume (30 Days) | 2.4M | ★ 3.4M |
| Earning Date | 05-05-2026 | 05-07-2026 |
| Dividend Yield | ★ 1.33% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $6,638,000,000.00 | $1,424,285,000.00 |
| Revenue This Year | $6.15 | $17.18 |
| Revenue Next Year | $5.95 | $14.02 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | 7.36 | ★ 13.85 |
| 52 Week Low | $10.44 | $3.74 |
| 52 Week High | $28.67 | $11.76 |
| Indicator | CC | LFST |
|---|---|---|
| Relative Strength Index (RSI) | 36.27 | 58.33 |
| Support Level | $15.99 | $6.23 |
| Resistance Level | $23.63 | $11.69 |
| Average True Range (ATR) | 0.90 | 0.37 |
| MACD | 0.01 | -0.13 |
| Stochastic Oscillator | 6.05 | 36.54 |
The Chemours Co is a provider of chemicals. It delivers customized solutions with a wide range of industrial and specialty chemicals products for various markets including coatings, plastics, refrigeration, air conditioning, paints and coatings, plastics, transportation, semiconductor, and others. The company's operating segments include Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. It generates maximum revenue from the Titanium Technologies segment. The Titanium Technologies segment is a producer of TiO2 pigment, a premium white pigment used to deliver whiteness, brightness, opacity, durability, efficiency, and protection across a variety of applications. Geographically, the company derives a majority of its revenue from North America.
LifeStance Health Group Inc is a mental healthcare company that operates as a provider of outpatient mental health services, spanning psychiatric evaluations and treatment, psychological and neuropsychological testing, and individual, family, and group therapy. It treats a broad range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder, using evidence-based approaches to ensure effective treatment. The group has a single operating and reportable segment of mental health services.